Filing Details
- Accession Number:
- 0000711377-18-000008
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-27 18:32:16
- Reporting Period:
- 2018-03-26
- Accepted Time:
- 2018-03-27 18:32:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
711377 | Neogen Corp | NEOG | In Vitro & In Vivo Diagnostic Substances (2835) | 382367843 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1517426 | J. Steven Quinlan | 620 Lesher Place Lansing MI 48912 | Vp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-03-26 | 1,733 | $29.71 | 15,203 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2018-03-26 | 1,133 | $35.34 | 16,336 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-03-26 | 2,866 | $64.97 | 13,470 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Common Stock (Right to Buy) | Disposition | 2018-03-26 | 1,733 | $0.00 | 1,733 | $29.71 |
Common Stock | Common Stock (Right to Buy) | Disposition | 2018-03-26 | 1,133 | $0.00 | 1,133 | $35.34 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
143,869 | 2019-10-31 | No | 4 | M | Direct | |
142,736 | 2020-11-08 | No | 4 | M | Direct |
Footnotes
- Options were granted 10/1/2014, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant
- Options were granted 10/8/2015, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant